IL6 and lung cancer: A study on the natural compound polyphyllin I pointed out that the regulation of IL‐6/STAT3 signalling EGFR‐TKI may reverse epithelial‐to‐mesenchymal transition and serve as a potential new way to overcome the EGFR‐TKI resistance in lung cancer.14